Based on data from a randomized trial presented at ESMO, the Netherlands Cancer Institute is exploring the possibility of seeking regulatory approval for TIL therapy without pharma involvement.
The consortium, which includes 13 studies in seven countries, was formed to support breast cancer genetic research across Latin American and Hispanic populations.
Many supposed breast cancer risk genes don t raise risk, studies find inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.